Allarity Therapeutics Inc (ALLR) concluded trading on Wednesday at a closing price of $1.07, with 25.86 million shares of worth about $27.67 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -81.94% during that period and on January 08, 2025 the price saw a gain of about 5.94%. Currently the company’s common shares owned by public are about 4.43M shares, out of which, 3.96M shares are available for trading.
Stock saw a price change of -8.55% in past 5 days and over the past one month there was a price change of -2.73%. Year-to-date (YTD), ALLR shares are showing a performance of -8.55% which decreased to -99.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.90 but also hit the highest price of $327.18 during that period. The average intraday trading volume for Allarity Therapeutics Inc shares is 606.98K. The stock is currently trading 2.20% above its 20-day simple moving average (SMA20), while that difference is down -10.38% for SMA50 and it goes to -94.06% lower than SMA200.
Allarity Therapeutics Inc (NASDAQ: ALLR) currently have 4.43M outstanding shares and institutions hold larger chunk of about 0.49% of that.
The stock has a current market capitalization of $4.75M and its 3Y-monthly beta is at 0.19. It has posted earnings per share of -$883.45 in the same period. It has Quick Ratio of 2.75 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALLR, volatility over the week remained 23.75% while standing at 16.43% over the month.
